SCHEMBL2201050

SCHEMBL2201050

COc1ccc(C(=O)NCC(O)CO)cc1C(=O)c1ccc(Nc2ccccc2)cc1Cl

nearest known ligand 0.47

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 4/20 0.47
MAPK13 O15264 2/20 0.47
MAPK12 P53778 2/20 0.47
MAPK11 Q15759 2/20 0.47
MEN1 O00255 5/20 0.45
KMT2A Q03164 5/20 0.45
PPARG P37231 1/20 0.44
OPRD1 P41143 1/20 0.41
APLNR P35414 1/20 0.41
HDAC8 Q9BY41 3/20 0.40
ALDH1A1 P00352 3/20 0.40
KDM4E B2RXH2 2/20 0.40
HPGD P15428 1/20 0.40
KCNA3 P22001 1/20 0.39
NPC1 O15118 1/20 0.38
HTT P42858 1/20 0.38
RAB9A P51151 1/20 0.38
KCNH2 Q12809 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2198174 0.92 MAPK14 (0.43) MAPK14MAPK13MAPK12MAPK11MEN1
SCHEMBL2197347 0.89 MAPK13 (0.49) MAPK14MAPK13MAPK12MAPK11MEN1
SCHEMBL2198948 0.88 MAPK14 (0.42) MAPK14MAPK13MAPK12MAPK11MEN1
SCHEMBL2198835 0.87 MAPK13 (0.51) MAPK14MAPK13MAPK12MAPK11MEN1
SCHEMBL2199008 0.85 MAPK14 (0.53) MAPK14MAPK13MAPK12MAPK11
SCHEMBL2196998 0.84 MAPK13 (0.51) MAPK14MAPK13MAPK12MAPK11MEN1
SCHEMBL2199303 0.84 MAPK13 (0.50) MAPK14MAPK13MAPK12MAPK11MEN1
SCHEMBL2200495 0.82 MAPK13 (0.59) MAPK14MAPK13MAPK12MAPK11MEN1
SCHEMBL2200691 0.81 MAPK13 (0.46) MAPK14MAPK13MAPK12MAPK11MEN1
SCHEMBL2200856 0.81 MAPK13 (0.58) MAPK14MAPK13MAPK12MAPK11MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060166990-A1 Novel aminobenzophenone compounds LEO PHARMA A/S (DK) 2006-07-27 US claimed
US-7977387-B2 Aminobenzophenone compounds LEO PHARMA A/S (DK) 2011-07-12 US disclosed
US-7977387-B2 Aminobenzophenone compounds LEO PHARMA A/S (DK) 2011-07-12 US disclosed
US-7977387-B2 Aminobenzophenone compounds LEO PHARMA A/S (DK) 2011-07-12 US disclosed
US-20060166990-A1 Novel aminobenzophenone compounds LEO PHARMA A/S (DK) 2006-07-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060166990-A1 Novel aminobenzophenone compounds NFKBIA, UACA, ALDH7A1 MAPK14 697/4885MAPK13 1063/4885MAPK12 955/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.